HALO Precision Diagnostics (HALO) is an integrated healthcare diagnostics company offering rapid, precise, and actionable results that create life-changing and life-saving individualized plans for patients.<\/i><\/p>\n
The Peoples Health Care is a California based non-profit organization committed to investing in the quality of care offered to the lives covered within California.<\/i><\/p>\n
MIAMI–(BUSINESS WIRE<\/a>)– This press release features multimedia. View the full release here: https:\/\/www.businesswire.com\/news\/home\/20230426005340\/en\/<\/a><\/p>\n (Photo: Business Wire)<\/p>\n<\/div>\n \nThe Peoples Health Care is a California based non-profit organization committed to investing in the quality of care offered to the lives covered within California. As part of this mission, Safe & Green Holdings is beginning their alignment with Teamsters Local 848 by delivering four (4) full mobile medical modules to the union, redefining pathways and deployment, increasing access to care, and ensuring that the union members and their families have a personalized and defined path to improved outcomes.<\/p>\n \nBy the conclusion of 2023, Safe & Green Holdings will have delivered one (1) Testing Module, one (1) CLIA Lab Facility Module and two (2) Primary Care Modules, all ADA compliant, and equipped to unlock quality care for the Teamsters Local 848 population. Services are expected to begin with general wellness visits, vaccines, laboratory medicine, select specialty visits, urgent care, imaging, diagnostics, and pharmacy services, making Halo an important partner in this mission.<\/p>\n \n\u201cAt Safe & Green Holdings, we are committed to shaping the future of medicine through sustainable and nimble healthcare solutions that empower the patient. To us, that means ensuring accessible, convenient, and agile care, for both patients and providers. The current centralized healthcare model is unable to easily adapt to the consumerization of healthcare services, and we intend to be the solution for lives here in the United States and abroad,\u201d said Paul Galvin, Chairman and CEO of Safe & Green Holdings Corp. \u201cWe are incredibly proud to partner with HALO Precision Diagnostics and The Peoples Health Care, two progressive and focused organizations, so that we can, together, unlock improved health outcomes for the lives of Local 848,\u201d continued Galvin.<\/p>\n \n\u201cCollectively with Safe & Green Holdings, we have committed ourselves to empowering union members with accessible, affordable, and democratized precision diagnostic healthcare,\u201d explained HALO CEO Michael Uhl. \u201cThis is a powerful way to expand our collective reach in order to bring personalized healthcare to patients, and we are thrilled to be part of such a novel ecosystem with the teams at Safe & Green Holdings,\u201d continued Uhl.<\/p>\n \nThe Company will continue to provide updates as the medical modules are delivered and new partners are engaged.<\/p>\n About Safe & Green Holdings Corp. About HALO Precision Diagnostics Safe Harbor Statement View source version on businesswire.com: <\/span>https:\/\/www.businesswire.com\/news\/home\/20230426005340\/en\/<\/a><\/span><\/p>\n Investor Relations: KEYWORDS:<\/b> California Florida United States North America<\/p>\n INDUSTRY KEYWORDS:<\/b> Commercial Building & Real Estate Construction & Property Managed Care Other Health Health General Health Radiology Pharmaceutical Building Systems Hospitals Other Construction & Property<\/p>\n
\nSafe & Green Holdings Corp. (NASDAQ: SGBX) (\u201cSafe & Green Holdings” or the \u201cCompany\u201d), a leading developer, designer, and fabricator of modular structures, announced today that the Company is further solidifying its position as a leader in proactive, patient-centered healthcare deliverance. Safe & Green Holdings is building off of its proven business model of providing deployable and sustainable infrastructure in order to capitalize on the healthcare industry\u2019s paradigm shift to point-of-care health models. The Company plans to bring higher quality and more equitable healthcare to underserved communities, while capturing its share of what is expected to be a nearly $52B market before the turn of 2030. Incorporating HALO Precision Diagnostics into this mission is expected to unlock care guided by integrated healthcare that is more cost effective, more accurate, and less invasive than traditional clinical diagnostic laboratory and imaging models, making them an ideal partner for Safe & Green Holdings and The Peoples Health Care.<\/p>\n![\"(Photo:](\"https:\/\/mms.businesswire.com\/media\/20230426005340\/en\/1774736\/4\/image002.jpg\")
<\/p>\n
\n
<\/span><\/b>Safe & Green Holdings Corp., a leading modular solutions company, operates under core capabilities which include the development, design, and fabrication of modular structures, meeting the demand for safe and green solutions across various industries. The firm supports third party and in-house developers, architects, builders and owners in achieving faster execution, greener construction, and buildings of higher value. Safe and Green Development Corporation is a leading real estate development company. Formed in 2021, the company focuses on the development of sites using purpose built, prefabricated modules built from both wood & steel, sourced from one of Safe & Green Holdings factories and operated by SG Echo. For more information, visit www.safeandgreenholdings.com<\/a> and follow us at @SGHcorp on Twitter.<\/p>\n
\n
<\/span><\/b>HALO Precision Diagnostics\u2122<\/sup> is the leader in early disease detection using precision diagnostics. The company’s outpatient Precision Diagnostic Centers\u2122<\/sup> are reshaping the healthcare ecosystem by integrating advanced imaging, digital pathology, molecular genomics, and predictive analytics under one roof, in a lower-cost, outpatient setting. HALO makes early-stage disease screening and diagnosis faster and more convenient for patients and physicians alike. With a HALO PathWay\u2122<\/sup> for breast, prostate, neuro, and cardiac disease, HALO is increasing early disease detection and saving lives. HALO currently serves 1 million patients, a number expected to triple by 2024. For more information, visit halodx.com<\/a>.<\/p>\n
\n
<\/span><\/b>Certain statements in this press release constitute “forward-looking statements” within the meaning of the federal securities laws. Words such as “may,” “might,” “will,” “should,” “believe,” “expect,” “anticipate,” “estimate,” “continue,” “predict,” “forecast,” “project,” “plan,” “intend” or similar expressions, or statements regarding intent, belief, or current expectations, are forward-looking statements. These forward-looking statements are based upon current estimates and assumptions and include statements regarding the Company capitalizing on the healthcare industry\u2019s paradigm shift to point-of-care health models, bringing higher quality and more equitable healthcare to underserved communities, capturing a share of what is expected to be a nearly $52B market before the turn of 2030, incorporating HALO Precision Diagnostics into the Company\u2019s mission unlocking care guided by integrated healthcare that is more cost effective, more accurate, and less invasive than traditional clinical diagnostic laboratory and imaging models, HALO being an ideal partner for Safe & Green Holdings and The Peoples Health Care, delivering four (4) full mobile medical modules to the Teamsters Local 848 by the conclusion of 2023, redefining pathways and deployment, increasing access to care, and ensuring that the union members and their families have a personalized and defined path to improved outcomes, services beginning with general wellness visits, vaccines, laboratory medicine, select specialty visits, urgent care, imaging, diagnostics, and pharmacy services, shaping the future of medicine through sustainable and nimble healthcare solutions that empower the patient, being the solution for lives here in the United States and abroad and providing updates as medical modules are delivered and new partners are engaged. While the Company believes these forward-looking statements are reasonable, undue reliance should not be placed on any such forward-looking statements, which are based on information available to us on the date of this release. These forward-looking statements are subject to various risks and uncertainties, many of which are difficult to predict that could cause actual results to differ materially from current expectations and assumptions from those set forth or implied by any forward-looking statements. Important factors that could cause actual results to differ materially from current expectations include, among others, the Company\u2019s ability to capitalize on the healthcare industry\u2019s shift to point-of-care health models, the Company\u2019s ability to bring higher quality and more equitable healthcare to underserved communities and capture a share of what is expected to be a nearly $52B market before the turn of 2030, the Company\u2019s ability to unlock care guided by integrated healthcare that is more cost effective, more accurate, and less invasive than traditional clinical diagnostic laboratory and imaging models by incorporating HALO Precision Diagnostics into the Company\u2019s mission, the Company\u2019s ability to deliver four (4) full mobile medical modules to the Teamsters Local 848 by the conclusion of 2023, the Company\u2019s ability to provide medical and pharmacy services as planned, the Company\u2019s ability to engage new partners, the Company\u2019s ability to spin out Safe and Green Development Corporation, the Company\u2019s ability to expand within various verticals as planned, the Company\u2019s ability to position itself for future profitability, the Company\u2019s ability to maintain compliance with the NASDAQ listing requirements, and the other factors discussed in the Company\u2019s Annual Report on Form 10-K for the year ended December 31, 2021 and its subsequent filings with the SEC, including subsequent periodic reports on Forms 10-Q and 8-K. The information in this release is provided only as of the date of this release, and we undertake no obligation to update any forward-looking statements contained in this release on account of new information, future events, or otherwise, except as required by law.<\/p>\n<\/p>\n
\n<\/b>
Crescendo Communications, LLC
\n
212-671-1020
\n
SGBX@crescendo-ir.com<\/a><\/p>\n
![\"Logo\"](\"https:\/\/mms.businesswire.com\/media\/20230426005340\/en\/1774734\/3\/SGLogo_1_BlkonClear.jpg\")
<\/td>\n<\/tr>\n![\"Photo\"](\"https:\/\/mms.businesswire.com\/media\/20230426005340\/en\/1774736\/3\/image002.jpg\")
<\/td>\n<\/tr>\n